Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity
Open accessThe DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Abstract
Tumours often engage the lymphatic system in order to invade and metastasize. The tumour-draining lymph node may be an immune-privileged site that protects the tumour from host immunity, and lymph flow that drains tumours is often increased, enhancing communication between the tumour and the sentinel node. In addition to increasing the transport of tumour antigens and regulatory cytokines to the lymph node, increased lymph flow in the tumour margin causes mechanical stress-induced changes in stromal cells that stiffen the matrix and alter the immune microenvironment of the tumour. We propose that synergies between lymphatic drainage and flow-induced mechanotransduction in the stroma promote tumour immune escape by appropriating lymphatic mechanisms of peripheral tolerance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although this shear stress is very small when compared with the intravascular shear stress, it can still stimulate some oncogenic signaling pathways on cancer cells [150] as well as upregulate TGFβ and activate fibroblast contraction to stiffen the ECM [151].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [151]
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 1×
“The hypoxia that is generated by a rapidly growing tumour mass drives aberrant tumour angiogenesis, which is one of the most well-studied hallmarks of cance”
BackgroundMyeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753 · cited 1×
“Myeloid-derived suppressor cells (MDSCs), which are important for immune suppression, as well as for tumour angiogenesis and invasio”
BackgroundKalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101 · cited 1×
“Additionally, transgenic expression of lysyl oxidase in mice could induce the invasion of otherwise non-invasive cancer cell”
BackgroundTensional homeostasis and the malignant phenotype
Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A., Reinhart-King, C. A., Margulies, S. S., Dembo, M., Boettiger, D., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.010 · Cited by 3,941
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Collective cell migration in morphogenesis, regeneration and cancer
Friedl, P., & Gilmour, D. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2720 · Cited by 2,712 · cited 1×
“Fibroblasts and tumour cells can also migrate along bundled collagen fibres that radiate outwards from the tumou”
BackgroundHigh Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222 · cited 1×
“, which, together with the leaky vessels, leads to increased interstitial fluid pressure (IFP) within the tumou”
BackgroundCollagen reorganization at the tumor-stromal interface facilitates local invasion
Provenzano, P. P., Eliceiri, K. W., Campbell, J. M., Inman, D. R., White, J. G., & Keely, P. J. (2006) · BMC Medicine · doi:10.1186/1741-7015-4-38 · Cited by 1,804 · cited 1×
“Fibroblasts and tumour cells can also migrate along bundled collagen fibres that radiate outwards from the tumou”
BackgroundGaggioli, C., Hooper, S., Hidalgo-Carcedo, C., Grosse, R., Marshall, J. F., Harrington, K., & Sahai, E. (2007) · Nature Cell Biology · doi:10.1038/ncb1658 · Cited by 1,589 · cited 1×
“Migrating CAFs, in turn, use proteases and generate forces to tunnel through the matrix, thereby leading collective tumour cell invasio”
Background
Research works printed but not linked: 1
- Ruddell, A., Harrell, M. I. & Furuya, M. Sentinel lymph node lymphangiogenesis and increased lymph flow in murine tumor metastasis. Clin. Exp. Metast. 26, 883–884 (2009).
Cited by
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
The tumor microenvironment at a glance
Balkwill, F. R., Capasso, M., & Hagemann, T. (2012) · Journal of Cell Science · doi:10.1242/jcs.116392 · Cited by 1,857
“…TME and lymphatic vessels formed by them have an important function in the dissemination of malignant cells, there is emerging evidence that they also affect the progression of cancer by mechanically modulating the TME and by altering the host immune response to the tumor (Swartz and Lund, 2012).”
BackgroundImmunological hallmarks of stromal cells in the tumour microenvironment
Turley, S. J., Cremasco, V., & Astarita, J. L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3902 · Cited by 1,140
The Role of Mechanical Forces in Tumor Growth and Therapy
Jain, R. K., Martin, J. D., & Stylianopoulos, T. (2014) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-105259 · Cited by 1,044
“Therefore, the composition of the interstitial space and particularly the hydraulic conductivity can regulate not only interstitial but also lymphatic flow (81).”
TGFβ biology in cancer progression and immunotherapy
Derynck, R., Turley, S. J., & Akhurst, R. J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0403-1 · Cited by 944
Nia, H. T., Munn, L. L., & Jain, R. K. (2020) · Science · doi:10.1126/science.aaz0868 · Cited by 855
Lymphangiogenesis and lymphatic vessel remodelling in cancer
Stacker, S. A., Williams, S. P., Karnezis, T., Shayan, R., Fox, S. B., & Achen, M. G. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3677 · Cited by 807
Physical influences of the extracellular environment on cell migration
Charras, G., & Sahai, E. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3897 · Cited by 702
From Sewer to Saviour—Targeting the Lymphatic System to Promote Drug Exposure and Activity
Trevaskis, N. L., Kaminskas, L. M., & Porter, C. J. H. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4608 · Cited by 654
Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
Schaaf, M. B., Garg, A. D., & Agostinis, P. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0061-0 · Cited by 629
Laklai, H., Miroshnikova, Y. A., Pickup, M. W., Collisson, E. A., Kim, G. E., Barrett, A. S., Hill, R. C., Lakins, J. N., Schlaepfer, D. D., Mouw, J. K., et al. (2016) · Nature Medicine · doi:10.1038/nm.4082 · Cited by 603
Stylianopoulos, T., Munn, L. L., & Jain, R. K. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2018.02.005 · Cited by 563
Perioperative events influence cancer recurrence risk after surgery
Hiller, J. G., Perry, N. J., Poulogiannis, G., Riedel, B., & Sloan, E. K. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.194 · Cited by 556
Microfluidic 3D cell culture: from tools to tissue models
van Duinen, V., Trietsch, S. J., Joore, J., Vulto, P., & Hankemeier, T. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.05.002 · Cited by 500
“An important driver in tumor migration is interstitial flow [53 ,54].”
Tian, C., Clauser, K. R., Öhlund, D., Rickelt, S., Huang, Y., Gupta, M., Mani, D. R., Carr, S. A., Tuveson, D. A., & Hynes, R. O. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908626116 · Cited by 425
Targeting TGFβ signal transduction for cancer therapy
Liu, S., Ren, J., & ten Dijke, P. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00436-9 · Cited by 413
Fluids and their mechanics in tumour transit: shaping metastasis
Follain, G., Herrmann, D., Harlepp, S., Hyenne, V., Osmani, N., Warren, S. C., Timpson, P., & Goetz, J. G. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0221-x · Cited by 412
Podoplanin: emerging functions in development, the immune system, and cancer
Astarita, J. L., Acton, S. E., & Turley, S. J. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00283 · Cited by 402
“Given that it is a specific marker of lymphatic vessels, and that increased lymphangiogenesis is often correlated with poor prognosis in cancer patients, the numbers of PDPN+ vessels in a tumor is often used as a diagnostic marker (Breiteneder-Geleff et al., 1997; Ji, 2006; Swartz and Lund, 2012).”
BackgroundCancer associated fibroblasts: An essential role in the tumor microenvironment
Tao, L., Huang, G., Song, H., Chen, Y., & Chen, L. (2017) · Oncology Letters · doi:10.3892/ol.2017.6497 · Cited by 351
“The interstitial fluid pressure (IFP) in the center of solid tumors is increased compared with that in the surrounding tumor tissue (59).”
The lymphatic system: integral roles in immunity
Randolph, G. J., Ivanov, S., Zinselmeyer, B. H., & Scallan, J. P. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055354 · Cited by 338
“Interstitial pressure in tumors is high, and this may favor the tumor in multiple ways (27).”
BackgroundEffect of Stromal Cells in Tumor Microenvironment on Metastasis Initiation
Guo, S., & Deng, C.-X. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.25720 · Cited by 315
Immunoengineering: How Nanotechnology Can Enhance Cancer Immunotherapy
Goldberg, M. S. (2015) · Cell · doi:10.1016/j.cell.2015.03.037 · Cited by 278
“Beyond enhancing our appreciation of the cellular and biochemical constituents of the tumor microenvironment, we will benefit from an increased consideration of the physical microenvironment in the tumor, as well as its draining lymph nodes (Swartz and Lund, 2012).”
BackgroundEngineering and physical sciences in oncology: challenges and opportunities
Mitchell, M. J., Jain, R. K., & Langer, R. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.83 · Cited by 273
Ji, H., Hu, C., Yang, X., Liu, Y., Ji, G., Ge, S., Wang, X., & Wang, M. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01576-4 · Cited by 250
“155,156 A growing number of studies have explored the associations between thoracic visceral tumors, such as esophageal and lung cancers, and thoracic LNs.”
BackgroundInfluentialFluid shear stress activates YAP1 to promote cancer cell motility
Lee, H. J., Diaz, M. F., Price, K. M., Ozuna, J. A., Zhang, S., Sevick-Muraca, E. M., Hagan, J. P., & Wenzel, P. L. (2017) · Nature Communications · doi:10.1038/ncomms14122 · Cited by 258
“Fluid frictional force or wall shear stress (WSS), is pervasive in egress routes from solid tumours and influences cytokine production and immune cell adhesion in lymphatic and venous vasculatures 2 .”
The role of the myofibroblast in tumor stroma remodeling
Otranto, M., Sarrazy, V., Bonté, F., Hinz, B., Gabbiani, G., & Desmouliere, A. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20377 · Cited by 250
Macrophage Reprogramming and Cancer Therapeutics: Role of iNOS-Derived NO
Kashfi, K., Kannikal, J., & Nath, N. (2021) · Cells · doi:10.3390/cells10113194 · Cited by 225
“In addition, research delineates their role in influencing host tumor responses [46].”
BackgroundTissue Force Programs Cell Fate and Tumor Aggression
Northey, J. J., Przybyla, L., & Weaver, V. M. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0733 · Cited by 237
“These forces cause fluid to accumulate in the interstitial space, resulting in a gradual increase in interstitial pressure that can impede drug delivery to a tumor (14, 72).”
BackgroundMansurov, A., Ishihara, J., Hosseinchi, P., Potin, L., Marchell, T. M., Ishihara, A., Williford, J.-M., Alpar, A. T., Raczy, M. M., Gray, L. T., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0549-2 · Cited by 235
Self-citationMicrofluidic modelling of the tumor microenvironment for anti-cancer drug development
Shang, M., Soon, R. H., Lim, C. T., Khoo, B. L., & Han, J. (2019) · Lab on a Chip · doi:10.1039/c8lc00970h · Cited by 227
Dubrot, J., Duraes, F. V., Potin, L., Capotosti, F., Brighouse, D., Suter, T., LeibundGut-Landmann, S., Garbi, N., Reith, W., Swartz, M. A., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132000 · Cited by 227
“More recently, however, studies have identified LNSCs as active players in modulating adaptive immune responses (Swartz and Lund, 2012).”
BackgroundSelf-citationLymphatic endothelial cells of the lymph node
Jalkanen, S., & Salmi, M. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0281-x · Cited by 226
Engineering Approaches to Immunotherapy
Swartz, M. A., Hirosue, S., & Hubbell, J. A. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003763 · Cited by 224
Self-citationOrgan-on-chip models of cancer metastasis for future personalized medicine: From chip to the patient
Caballero, D., Kaushik, S., Correlo, V. M., Oliveira, J. M., Reis, R. L., & Kundu, S. C. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.005 · Cited by 221
Computational and Experimental Models of Cancer Cell Response to Fluid Shear Stress
Mitchell, M. J., & King, M. R. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00044 · Cited by 221
“Cancer cells experience two main types of fluid shear stress: stresses generated by blood flow in the vascular microenvironment, and those generated by interstitial flows in the tumor microenvironment (Michor et al., 2011; Swartz and Lund, 2012).”
BackgroundLymphatic vessels regulate immune microenvironments in human and murine melanoma
Lund, A. W., Wagner, M., Fankhauser, M., Steinskog, E. S., Broggi, M. A., Spranger, S., Gajewski, T. F., Alitalo, K., Eikesdal, H. P., Wiig, H., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci79434 · Cited by 207
“The finding that some patients lack tumorinfiltrating lymphocytes and consequently demonstrate poor response to immunotherapy (28, 29) indicates that endogenous mechanisms regulating immune induction in the tumor may be responsible for therapeutic resistance (4).”
BackgroundSelf-citationHirosue, S., Vokali, E., Raghavan, V. R., Rincon-Restrepo, M., Lund, A. W., Corthésy-Henrioud, P., Capotosti, F., Halin Winter, C., Hugues, S., & Swartz, M. A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302492 · Cited by 204
Self-citationMitchell, M. J., & King, M. R. (2013) · New Journal of Physics · doi:10.1088/1367-2630/15/1/015008 · Cited by 196
Núñez, N. G., Tosello Boari, J., Ramos, R. N., Richer, W., Cagnard, N., Anderfuhren, C. D., Niborski, L. L., Bigot, J., Meseure, D., De La Rochere, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17046-2 · Cited by 199
Tumor Abnormality-Oriented Nanomedicine Design
Zhou, Q., Xiang, J., Qiu, N., Wang, Y., Piao, Y., Shao, S., Tang, J., Zhou, Z., & Shen, Y. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00062 · Cited by 188
Fluid shear stress and tumor metastasis.
Huang, Q., Hu, X., He, W., Zhao, Y., Hao, S., Wu, Q., Li, S., Zhang, S., & Shi, M. (2018) · Europe PMC (PubMed Central) · Cited by 256
Hendry, S. A., Farnsworth, R. H., Solomon, B., Achen, M. G., Stacker, S. A., & Fox, S. B. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00621 · Cited by 188
“In addition to this presentation of self-antigens, LECs activated by VEGF-C have also been shown to scavenge and cross-present tumor antigens, leading to the apoptosis of tumor-specific CD8+ T cells (181).”
BackgroundInfluentialChoi, Y., & Jung, K. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01114-w · Cited by 188
Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression
Seager, R. J., Hajal, C., Spill, F., Kamm, R. D., & Zaman, M. H. (2017) · Convergent Science Physical Oncology · doi:10.1088/2057-1739/aa7e86 · Cited by 186
Jo, Y., Choi, N., Kim, K., Koo, H.-J., Choi, J., & Kim, H. N. (2018) · Theranostics · doi:10.7150/thno.29098 · Cited by 183
“Cancer cells experience two main types of fluid shear stress—one that results from the flow of blood in the vascular microenvironment and the other generated by interstitial flows in the TME[141, 142].”
BackgroundLymphatic system: An active pathway for immune protection
Liao, S., & von der Weid, P. Y. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2014.11.012 · Cited by 174
Yeon, J. H., Jeong, H. E., Seo, H., Cho, S., Kim, K., Na, D., Chung, S., Park, J., Choi, N., & Kang, J. Y. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.07.001 · Cited by 173
The Importance of Mechanical Forces for in vitro Endothelial Cell Biology
Gordon, E., Schimmel, L., & Frye, M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00684 · Cited by 171
Leveraging Physiology for Precision Drug Delivery
Sun, W., Hu, Q., Ji, W., Wright, G., & Gu, Z. (2017) · Physiological Reviews · doi:10.1152/physrev.00015.2016 · Cited by 169
“However, the elevated IFP poses a barrier for the extravasation and diffusion of nanoparticles to different regions of the tumor, especially to the tumor parenchyma, leading to reduced yet heterogeneous drug delivery and compromising therapeutic efficacies (402).”
BackgroundEmerging Roles for VEGF-D in Human Disease
Stacker, S., & Achen, M. (2018) · Biomolecules · doi:10.3390/biom8010001 · Cited by 166
Interstitial Fluid Flow and Drug Delivery in Vascularized Tumors: A Computational Model
Welter, M., & Rieger, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070395 · Cited by 158
“Moreover tumors can induce lymph angiogenesis similar to normal angiogenesis [9]”
Metastasis review: from bench to bedside
Alizadeh, A. M., Shiri, S., & Farsinejad, S. (2014) · Tumor Biology · doi:10.1007/s13277-014-2421-z · Cited by 160
Vasculature-On-A-Chip for In Vitro Disease Models
Kim, S., Kim, W., Lim, S., & Jeon, J. (2017) · Bioengineering · doi:10.3390/bioengineering4010008 · Cited by 157
Three-dimensional biomimetic model to reconstitute sprouting lymphangiogenesis in vitro
Kim, S., Chung, M., & Jeon, N. L. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.019 · Cited by 157
“In order to closely mimic in vivo pathological context that promote lymphatic vessel remodeling, which is chara cterized by elevated expression of prolymphangiogenic factors, high interstitial fluid pr essure and increased lymph drainage [7, 19], we configured the experimental platform to be optim ized for combinatori…”
MethodExploring the Tumor Microenvironment with Nanoparticles
Miao, L., & Huang, L. (2015) · Cancer Treatment and Research · doi:10.1007/978-3-319-16555-4_9 · Cited by 144
“In normal tissues, IFP is around 0 mm Hg; whereas tumors, exhibiting interstitial hypertension, have an IFP almost identical to the microvascular pressure (with a range of 10–40 mm Hg) [66–68].”
BackgroundTissue mechanics in stem cell fate, development, and cancer
Hayward, M.-K., Muncie, J. M., & Weaver, V. M. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.05.011 · Cited by 160
Radiation effects on the tumor microenvironment: Implications for nanomedicine delivery
Stapleton, S., Jaffray, D. A., & Milosevic, M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.05.021 · Cited by 168
Releasing Pressure in Tumors: What Do We Know So Far and Where Do We Go from Here? A Review
Ariffin, A. B., Forde, P. F., Jahangeer, S., Soden, D. M., & Hinchion, J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3696 · Cited by 150
“These abnormalities causes an impairment in their drainage function (6).”
BackgroundPateras, I. S., Havaki, S., Nikitopoulou, X., Vougas, K. N., Townsend, P. A., Panayiotidis, M. I., Georgakilas, A. G., & Gorgoulis, V. G. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.011 · Cited by 156
Rofstad, E. K., Galappathi, K., & Mathiesen, B. S. (2014) · Neoplasia · doi:10.1016/j.neo.2014.07.003 · Cited by 154
“Thus, it has been observed that some tumors show overexpression of prolymphangiogenic factors and that these factors may evoke hyperplasia of peritumoral lymphatics and produce immature lymphatics with reduced draining capacity [47,48].”
BackgroundBroggi, M. A. S., Maillat, L., Clement, C. C., Bordry, N., Corthésy, P., Auger, A., Matter, M., Hamelin, R., Potin, L., Demurtas, D., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181618 · Cited by 135
Self-citationFabrication of 3D Biomimetic Microfluidic Networks in Hydrogels
Heintz, K. A., Bregenzer, M. E., Mantle, J. L., Lee, K. H., West, J. L., & Slater, J. H. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600351 · Cited by 137
Song, Y., Bugada, L. F., Li, R., Hu, H., Zhang, L., Li, C., Yuan, H., Rajanayake, K. K., Truchan, N. A., Wen, F., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl3649 · Cited by 139
The fluid shear stress sensor TRPM7 regulates tumor cell intravasation
Yankaskas, C. L., Bera, K., Stoletov, K. V., Serra, S. A., Carrillo-García, J., Tuntithavornwat, S., Mistriotis, P., Lewis, J. D., Valverde, M. A., & Κωνσταντόπουλος, Κ. (2021) · Science Advances · doi:10.1126/sciadv.abh3457 · Cited by 137
Biomaterials for enhancing anti-cancer immunity
Koshy, S. T., & Mooney, D. J. (2016) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2016.02.001 · Cited by 142
“The tumor-draining LN (TDLN), although bathed constantly in tumor antigen, can be a location of immune tolerance generation [41] and efforts have been made to deliver pro-inflammatory stimuli to APCs in the TDLN”
Lymphatic Dysfunction, Leukotrienes, and Lymphedema
Jiang, X., Nicolls, M. R., Tian, W., & Rockson, S. G. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034008 · Cited by 144
“The lymphatic vascular system is increasingly recognized to play an important role in a number of pathological conditions, such as tumor metastasis (86), chronic inflammation (87), metabolic diseases (69, 88), and cardiovascular diseases, such as atherosclerosis and myocardial infarction (40).”
The dark side of tumor-associated endothelial cells
Sanctis, F. D., Ugel, S., Facciponte, J. G., & Facciabene, A. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.02.002 · Cited by 143
“Additionally, it increases also lymph drainage to adjacent lymph nodes where tumor-secreted factors and immature antigen presenting cells (APCs), such as immature dendritic cells – iDCs, previously exposed to tumor microenvironment, are recruited and activate naïve T cells in a tolerogenic manner to promote peripheral…”
BackgroundThe Fluid Mechanics of Cancer and Its Therapy
Koumoutsakos, P., Pivkin, I., & Milde, F. (2013) · Annual Review of Fluid Mechanics · doi:10.1146/annurev-fluid-120710-101102 · Cited by 129
“Next to blood vessels, tumors often recruit their own lymphatic system, which drains excessive fluid from the interstitial tissue (Swartz & Lund 2012).”
BackgroundMethodInfluentialHuber, D., Oskooei, A., Solvas, X. C. I., deMello, A. J., & Kaigala, G. V. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00317 · Cited by 139
Voutouri, C., Polydorou, C., Papageorgis, P., Gkretsi, V., & Stylianopoulos, T. (2016) · Neoplasia · doi:10.1016/j.neo.2016.10.001 · Cited by 139
“On the other hand, elevated IFP poses an additional barrier to the delivery of nanoscale drugs and facilitates transport of growth factors and cancer cells from the tumor to the surrounding tissue, fueling tumor growth, progression, and lymphatic metastasis [21,22].”
BackgroundInterstitial flow promotes macrophage polarization toward an M2 phenotype
Li, R., Serrano, J. C., Xing, H., Lee, T. A., Azizgolshani, H., Zaman, M., & Kamm, R. D. (2018) · Molecular Biology of the Cell · doi:10.1091/mbc.e18-03-0164 · Cited by 125
Lymphatic function and immune regulation in health and disease
Liao, S., & Padera, T. P. (2013) · Lymphatic Research and Biology · doi:10.1089/lrb.2013.0012 · Cited by 122
“In addition, lymphatic endothelial cells can present tumor antigen and may induce immune tolerance.(107) All of these factors need to be considered in the development of immune therapy for metastatic tumors.”
BackgroundImpaired Humoral Immunity and Tolerance in K14-VEGFR-3-Ig Mice That Lack Dermal Lymphatic Drainage
Thomas, S. N., Rutkowski, J. M., Pasquier, M., Kuan, E. L., Alitalo, K., Randolph, G. J., & Swartz, M. A. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103545 · Cited by 120
“drainage is correlated with tumor progression (17, 18), and tumorassociated lymphangiogenesis was recently shown to promote immune tolerance (19, 20).”
Self-citationTumor-Associated Lymphatic Vessel Features and Immunomodulatory Functions
Garnier, L., Gkountidi, A.-O., & Hugues, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00720 · Cited by 120
Lamin A/C deficiency reduces circulating tumor cell resistance to fluid shear stress
Mitchell, M. J., Denais, C., Chan, M. F., Wang, Z., Lammerding, J., & King, M. R. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00050.2015 · Cited by 136
Low levels of physiological interstitial flow eliminate morphogen gradients and guide angiogenesis
Shirure, V. S., Lezia, A., Tao, A., Alonzo, L. F., & George, S. C. (2017) · Angiogenesis · doi:10.1007/s10456-017-9559-4 · Cited by 117
“interest in the tumor microenvironment, as the elevation of interstitial flow and vascular endothelial growth factor (VEGF) are both correlated with tumor progression [1, 3].”
BackgroundTargeting the tumor biophysical microenvironment to reduce resistance to immunotherapy
Zhang, T., Jia, Y., Yu, Y., Zhang, B., Xu, F., & Guo, H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114319 · Cited by 113
Lymphatic targeting by albumin-hitchhiking: Applications and optimisation
Abdallah, M., Müllertz, O. O., Styles, I. K., Mörsdorf, A., Quinn, J. F., Whittaker, M. R., & Trevaskis, N. L. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.046 · Cited by 114
Cancer Extracellular Matrix Proteins Regulate Tumour Immunity
Gordon-Weeks, A. N., & Yuzhalin, A. E. (2020) · Cancers · doi:10.3390/cancers12113331 · Cited by 131
Hompland, T., Ellingsen, C., Øvrebø, K. M., & Rofstad, E. K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0903 · Cited by 114
“the tumor-draining lymph node may be an immune-privileged site for metastatic growth because increased interstitial and lymphaticfluidflowmay alter the host immunity to tumor cells (45).”
BackgroundMolecular mechanisms of cancer metastasis via the lymphatic versus the blood vessels
Leong, S. P. L., Naxerova, K., Keller, L., Pantel, K., & Witte, M. H. (2021) · Clinical & Experimental Metastasis · doi:10.1007/s10585-021-10120-z · Cited by 133
“In this murine model of B16 F10 melanoma expressing a foreign antigen (OVA), Lund et al. has shown that VEGF-C promotes immune tolerance in murine melanoma.”
BackgroundPisano, M., Triacca, V., Barbee, K. A., & Swartz, M. A. (2015) · Integrative Biology · doi:10.1039/c5ib00085h · Cited by 114
Self-citationTumor Interstitial Fluid Formation, Characterization, and Clinical Implications
Wagner, M., & Wiig, H. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00115 · Cited by 131
“(99)], and have named this phenomenon autologous chemotaxis (100).”
BackgroundStructural ECM components in the premetastatic and metastatic niche
Høye, A. M., & Erler, J. T. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00326.2015 · Cited by 114
Yang, H., Wu, X., Zhou, Z., Chen, X., & Kong, M. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.11.230 · Cited by 110
Voutouri, C., Mpekris, F., Papageorgis, P., Odysseos, A. D., & Stylianopoulos, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104717 · Cited by 126
“Finally, compression of lymphatic vessels contributes to the uniform elevation of the interstitial fluid pressure due to the inability of the tumor to drain the excessive interstitial fluid [17].”
BackgroundLien, S.-C., Chang, S., Lee, P.-L., Wei, S., Chang, M. D., Chang, J., & Chiu, J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.08.023 · Cited by 117
Frahm, M., Felgner, S., Kocijancic, D., Rohde, M., Hensel, M., Curtiss, R., Erhardt, M., & Weiss, S. (2015) · mBio · doi:10.1128/mbio.00254-15 · Cited by 101
“For instance, the well-known leakiness of tumor neovasculature could lead to a shift in the Starling forces and result in increased interstitial flow from blood toward the lymphatic vessels (26).”
BackgroundInflammation-induced lymphangiogenesis and lymphatic dysfunction
Liao, S., & von der Weid, P. (2014) · Angiogenesis · doi:10.1007/s10456-014-9416-7 · Cited by 115
Photodynamic Therapy and the Biophysics of the Tumor Microenvironment
Sorrin, A. J., Ruhi, M. K., Ferlic, N. A., Karimnia, V., Polacheck, W. J., Celli, J. P., Huang, H., & Rizvi, I. (2020) · Photochemistry and Photobiology · doi:10.1111/php.13209 · Cited by 109
“gradient in the tumor margin, because of high tumor IFP, causes higher interstitial flow into the tumor stroma and the surrounding lymphatic vessels (59).”
BackgroundImmune cells as tumor drug delivery vehicles.
Combes, F., Meyer, E., & Sanders, N. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.043 · Cited by 83
“Combined with the production and remodeling of the ECM at the tumor margin [30,31], these anomalies lead to an increased interstitial fluid pressure within the tumor [32,33].”
BackgroundInterstitial Fluid Flow: The Mechanical Environment of Cells and Foundation of Meridians
Yao, W., Li, Y., & Ding, G. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/853516 · Cited by 98
“Recent studies showed that interstitial flow influences the immune microenvironment in cancer [28].”
BackgroundImmunomodulatory Roles of Lymphatic Vessels in Cancer Progression
Swartz, M. A. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0115 · Cited by 103
“This study and others suggest that DLNs are altered by the primary tumor to allow immune escape (either lack of immune recognition, or recognition and tolerance), and that the correlation between tumor-associated lymphatic vessels and lymph nodes metastasis is more complex than previously realized.”
BackgroundSelf-citationLymphatic Vessels, Inflammation, and Immunity in Skin Cancer
Lund, A. W., Medler, T. R., Leachman, S. A., & Coussens, L. M. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0023 · Cited by 102
“Lymphatic vessels develop as a hierarchical, one-way drainage system functioning to transport cells and fluid into the lymphoid system, and as a result of this architecture, lymphatic vessels lie at the interface of tissue biology and immunology (24).”
BackgroundInfluentialSelf-citationCancer cell glycocalyx mediates mechanotransduction and flow-regulated invasion
Qazi, H., Palomino, R., Shi, Z., Munn, L. L., & Tarbell, J. M. (2013) · Integrative Biology · doi:10.1039/c3ib40057c · Cited by 94
Gkountidi, A. O., Garnier, L., Dubrot, J., Angelillo, J., Harlé, G., Brighouse, D., Wrobel, L. J., Pick, R., Scheiermann, C., Swartz, M. A., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0784 · Cited by 99
“Tumoral LVs are required for the initiation of antitumor T-cell responses because they facilitate tumor–antigen drainage and DC migration from the tumor bed to the tumor-draining LNs (TdLN) where tumor-specific na€ ve T cells are activated (29).”
BackgroundSelf-citationSong, J., Miermont, A., Lim, C. T., & Kamm, R. D. (2018) · Scientific Reports · doi:10.1038/s41598-018-36381-5 · Cited by 87
Privat‐Maldonado, A., Bengtson, C., Razzokov, J., Smits, E., & Bogaerts, A. (2019) · Cancers · doi:10.3390/cancers11121920 · Cited by 91
The contractome – a systems view of actomyosin contractility in non-muscle cells
Zaidel‐Bar, R., Zhenhuan, G., & Luxenburg, C. (2015) · Journal of Cell Science · doi:10.1242/jcs.170068 · Cited by 96
“…the expanding research of non-muscle myosin II and mechanobiology in general have highlighted the fact that actomyosin contractility plays a key role in many structural, mechanical and regulatory processes (Eyckmans et al., 2011; Mammoto et al., 2013; Sun and Fu, 2013; Swartz and Lund, 2012).”
BackgroundLymphatic Tissue Engineering and Regeneration
Alderfer, L., Wei, A. Y., & Hanjaya‐Putra, D. (2018) · Journal of Biological Engineering · doi:10.1186/s13036-018-0122-7 · Cited by 95
Metadata
- Authors
- Swartz, M. A., & Lund, A. W.
- Affiliations
- École Polytechnique Fédérale de Lausanne (CH)
- Corresponding author
- Swartz, Melody A.
- Venue
- Nature Reviews Cancer
- Published
- 2012-02-24
- Volume
- 12
- Issue
- 3
- Pages
- 210-219
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1985830305
- Semantic Scholar
- dde3a2ceebef487db2c0e2c5a80a8718f401a39b
- Cited by
- 544
- References
- 131
- Citations by year
- 2026: 32 · 2025: 32 · 2024: 35 · 2023: 41 · 2022: 37 · 2021: 46 · 2020: 52 · 2019: 33 · 2018: 51 · 2017: 50 · 2016: 32 · 2015: 29 · 2014: 27 · 2013: 37 · 2012: 9
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Topics
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- tumor microenvironment, lymph flow, interstitial fluid flow, mechanobiology, mechanotransduction, tumor stroma, tumor immune evasion, tumor-draining lymph nodes, sentinel lymph node, tumour metastasis, tumor invasion, peripheral tolerance, tumor antigens
- MeSH terms
- Animals, Humans, Lymph Nodes, Lymphatic Metastasis, Neoplasms, Tumor Escape, Mechanotransduction, Cellular, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.